Latest Cerebral aneurysm Stories
MAPLE GROVE, Minn., April 5, 2011 /PRNewswire/ -- NeuroVasx announced today that the FDA has approved the cPAX Aneurysm Treatment System as a Humanitarian Use Device (HDE) for the treatment of large, giant and wide-neck cerebral aneurysms, which are typically the most difficult to treat.
From the invention of angioplasty and the catheter-delivered stent, which were both first used to treat peripheral arterial disease in the legs, to drug-coated stents, balloon angioplasty, ozone generators and radiofrequency ablation and clot-removing devices of today â€“ interventional radiologists have continued to shape and change the medical landscape and improve patient care.
Option for those at greater risk for stroke during standard bypass surgery SILVER SPRING, Md., March 10, 2011 /PRNewswire-USNewswire/ -- The U.S.
PALO ALTO, Calif., Feb.
PALO ALTO, Calif., Jan. 11, 2011 /PRNewswire/ -- Nfocus Neuromedical, Inc., an innovative medical device company with a focus on the next generation treatment for brain aneurysms, today announced that the company received U.S.
HCA Gulf Coast Division and The Joe Niekro Foundation â€œKnuckle-Upâ€ to Strike Out Aneurysms HCA Gulf Coast Division and The Joe Niekro Foundation present the second annual â€œKnuckle Ballâ€”A Pitch for Lifeâ€ on Saturday, November 13th at Minute Maid Park.
PALO ALTO, Calif., Oct. 25 /PRNewswire/ -- Nfocus Neuromedical Inc., an innovative medical device company focused on the next generation treatment for brain aneurysms, today announced the appointment of Eric Milledge to Chairman and CEO effective immediately.
NEW BRUNSWICK, N.J., Sept. 27 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) today announced that it has completed the acquisition of Micrus Endovascular, a global developer and manufacturer of minimally invasive devices for hemorrhagic and ischemic stroke.
The large Nordic twin study investigating the heritability of subarachnothe role of genetic factors underlying the development of SAH suggests that the role of genetic factors underlying the development of SAH is less than previously believed.
TUSTIN, Calif., Aug.
- A person in a secondary role, specifically the second most important character (after the protagonist).